MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP

We are thrilled to announce the official opening of αLab in the Hong Kong Science & Technology Parks (HKSTP), the city’s largest R&D base and one of the most important incubators. Integrating artificial intelligence R&D, application transformation and incubation platform, the brand-new laboratory aims to empower the development of the life sciences industry in Hong Kong and the rest of the world through strengthened global collaboration.

αLab, the first phase of MGI lab in HKSTP, also marks the first application of smart lab in Hong Kong. The new αLab will also be home to MGI’s first AI laboratory in Hong Kong which serves as the company's research and development centre focusing on cutting-edge AI technology and industry applications.

In the near future, the second phase of MGI lab in HKSTP, DCS Lab, will empower and advance three fields in frontier science – namely population genomics, single-cell omics and spatiotemporal omics with MGI’s state-of-the-art tools and technology.

About MGI
MGI Tech Co., Ltd. (or its affiliates, "MGI"), headquartered in Shenzhen, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments*, reagents*, and related products to support life science research, agriculture, precision medicine and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare. As of December 31, 2022, MGI has more than 2,800 employees, and 36% of whom are R&D personnel. Founded in 2016, MGI operates in more than 90 countries and regions, serving more than 2,000 customers.